Clinical trial
Descartes-08 for Children, Adolescents and Young Adults With Childhood-onset Systemic Lupus Erythematosus, ANCA-associated Vasculitis, Juvenile Myasthenia Gravis, and Juvenile Dermatomyositis
NCT07089121 is registered in ClinicalTrials.gov with Cartesian Therapeutics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Descartes-08 for Children, Adolescents and Young Adults With Childhood-onset Systemic Lupus Erythematosus, ANCA-associated Vasculitis, Juvenile Myasthenia Gravis, and Juvenile Dermatomyositis
- Lead sponsor
- Cartesian Therapeutics
- Phase
- Phase 1/2
- Overall status
- Recruiting
- Start date
- January 14, 2026
- Completion date
- December 31, 2028
- Enrollment
- 50 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
anca-associated vasculitis (aav), childhood-onset systemic lupus erythematous, juvenile dermatomyositis, juvenile myasthenia gravis